Target intelligence / Profile preview

Guanine nucleotide-binding protein subunit alpha-q (GNAQ) and Guanine nucleotide-binding protein subunit alpha-11 (GNA11) (GNAQ, GNA11)

Target
GNAQ, GNA11
Molecular classification
G protein alpha subunit (Gαq, Gα11), Signal transduction protein, Heterotrimeric G protein, Downstream effector of G protein-coupled receptor (GPCR) signaling, Oncogene (when mutated)
01

Overview

GNAQ and GNA11 encode two closely related alpha subunits of heterotrimeric G proteins (Gαq and Gα11), responsible for transducing signals from G protein-coupled receptors (GPCRs) to intracellular effectors, such as phospholipase C-beta. Mutation of GNAQ or GNA11, especially at codons Q209 and R183, leads to constitutive activation of these subunits, resulting in persistent signaling and oncogenic transformation, particularly in uveal melanoma and other melanocytic neoplasms. Both proteins play essential roles in normal cellular physiology including regulation of calcium signaling, cell proliferation, differentiation, and apoptosis.

Other names
GNAQ: G protein subunit alpha qGNAQ: GαqGNA11: G protein subunit alpha 11GNA11: Gα11Collectively: Gq class alpha subunitsCollectively: Gαq/11
02

Mechanism of action

Inhibition of downstream signaling cascades (MAPK/ERK, PKC, etc.) that become constitutively active in presence of GNAQ/GNA11 mutations. Attempts to directly target mutated Gαq/11 function, often via interfering in GPCR signaling or phospholipase C-beta activation.

03

Biological functions

Signal transduction (transducing signals from cell-surface GPCRs to intracellular effectors)Mediation of phospholipase C-beta activationRegulation of calcium signaling via interaction with calcium-sensing receptorsRegulation of cell proliferation, differentiation, and apoptosisInfluences blood calcium levels
04

Disease associations

Cancer (especially uveal melanoma, blue nevi, leptomeningeal melanocytosis)Sturge-Weber syndrome, port-wine stainsOther melanocytic lesionsDisorders linked to calcium homeostasis (via GNA11 mutations)
05

Safety considerations

Therapeutic challenge: Direct targeting of mutant GNAQ/GNA11 has proven difficult due to the ubiquitous physiological role of wild-type G proteins and their essential functionsDrug specificity: Potential off-target effects and toxicity due to inhibition of normal G protein signaling
06

Interacting drugs

Specific targeted drugs for mutant GNAQ/GNA11 are still in research/preclinical stages and generally target downstream effectors (such as MEK, PKC, and PI3K inhibitors). Direct inhibitors of the mutant proteins themselves are not clinically approved
07

Biomarkers

Mutational status of GNAQ (especially Q209 and R183 mutations) and GNA11 (Q209 and R183 mutations) in tumor tissue serve as biomarkers for diagnostics and prognostics in uveal melanoma and related lesionsHyperactivation markers of MAPK/ERK and PKC pathways may reflect GNAQ/GNA11 mutation status

Beyond the preview

Go deeper on Guanine nucleotide-binding protein subunit alpha-q (GNAQ) and Guanine nucleotide-binding protein subunit alpha-11 (GNA11) (GNAQ, GNA11).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guanine nucleotide-binding protein subunit alpha-q (GNAQ) and Guanine nucleotide-binding protein subunit alpha-11 (GNA11) (GNAQ, GNA11).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call